1,7-phenanthroline has been researched along with ursodeoxycholic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabiddu, MG; Cadoni, E; Gabrielová, V; Havel, J; Masuri, S; Meloni, F; Moráň, L; Pečinka, L; Pivetta, T; Vaňhara, P; Vesselá, T | 1 |
1 other study(ies) available for 1,7-phenanthroline and ursodeoxycholic acid
| Article | Year |
|---|---|
A novel heteroleptic Cu(II)-phenanthroline-UDCA complex as lipoxygenase inhibitor and ER-stress inducer in cancer cell lines.
Topics: Apoptosis; Cell Line; Copper; Endoplasmic Reticulum Stress; Enzyme Inhibitors; Lipoxygenase Inhibitors; Molecular Docking Simulation; Neoplasms; Pancreatic Neoplasms; Phenanthrolines; Ursodeoxycholic Acid | 2023 |